American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
Upgrade
American Flag

ENZ

ENZ Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News

Chart provided by TradingView

ENZ historical prices
Income
Balance Sheet
Cash Flow
Revenue Breakdown
Congress Trading

Recent trades of ENZ by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
ENZ Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
ENZ Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
ENZ Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes in ENZ holdings by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard
Insider Trading

Quarterly net insider trading by ENZ's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
View Strategy Copytrade Strategy
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

See Pricing
schema-2
Corporate Lobbying

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
Revolving Door

Former government officials who have lobbied for ENZ

Quiver Logo

No former government officials on record as having lobbied for ENZ

Revolving Door Dashboard
Corporate Lobbying

ENZ Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard
Revenue Breakdown

ENZ Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
ENZ Income Statement
ENZ Balance Sheet
ENZ Cash Flow
U.S. Patents

New ENZ patent grants

  • Patent Title: Dna labeling compositions and methods for comparative genomic hybridization Oct. 14, 2025
  • Patent Title: Fluorescence quencher polymer conjugates and uses thereof Oct. 22, 2024
  • Patent Title: Diagnosis and treatment of viral diseases Aug. 13, 2024
  • Patent Title: Pharmaceutical compositions and methods targeting wnt pathway proteins Mar. 26, 2024
  • Patent Title: Sphingosine pathway modulating compounds for the treatment of coronavirus infection Mar. 19, 2024
  • Patent Title: Sphingosine pathway modulating compounds for the treatment of cancers Jan. 09, 2024
  • Patent Title: Sphingosine pathway modulating compounds for the treatment of coronavirus infection Aug. 15, 2023
  • Patent Title: Sulfonated sclerostin, antibodies, epitopes and methods for identification and use therefor Jun. 06, 2023
  • Patent Title: Antibodies specific for sulfation sites of wnt pathway proteins May. 02, 2023
  • Patent Title: Sphingosine pathway modulating compounds for the treatment of coronavirus infection Jan. 17, 2023
  • Patent Title: Immunomodulatory pharmaceutical compositions including a synthetic peptide and transforming growth factor beta Nov. 16, 2021
  • Patent Title: Methods for treating bone loss using sclerostin peptides Nov. 09, 2021
  • Patent Title: Affinity tag nucleic acid and protein compositions, and processes for using same Jul. 20, 2021
  • Patent Title: Antibodies specific for sulfation sites of sclerostin Jan. 26, 2021
  • Patent Title: Sphingosine pathway modulating compounds for the treatment of cancers Jan. 05, 2021
  • Patent Title: Monoazo dyes with cyclic amine as fluorescence quenchers Dec. 15, 2020
  • Patent Title: Immunomodulatory pharmaceutical compositions Jul. 14, 2020
  • Patent Title: Methods and intermediates for synthesizing sk1-i Jun. 16, 2020
  • Patent Title: Sphingosine pathway modulating compounds for the treatment of cancers May. 26, 2020
  • Patent Title: Sphingosine pathway modulating compounds for the treatment of cancers May. 12, 2020
  • Patent Title: Diagnosis and treatment of viral diseases Dec. 03, 2019
  • Patent Title: Methods and intermediates for synthesizing sk1-i Jul. 30, 2019
  • Patent Title: Monoazo dyes with cyclic amine as fluorescence quenchers May. 01, 2018
  • Patent Title: Monoazo dyes with cyclic amine as fluorescence quenchers Apr. 24, 2018
  • Patent Title: Diagnosis and treatment of viral diseases Apr. 03, 2018
  • Patent Title: Dyes and compositions, and processes for using same in analysis of protein aggregation and other applications Apr. 03, 2018
  • Patent Title: Compositions and processes for analyte detection, quantification and amplification Jan. 23, 2018
  • Patent Title: Process for detecting or quantifying nucleic acids in a library Oct. 03, 2017
  • Patent Title: Process for detecting or quantifying nucleic acids in a library Sep. 19, 2017
  • Patent Title: Process for detecting or quantifying nucleic acids in a library Aug. 29, 2017
  • Patent Title: Processes for detecting or quantifying nucleic acids using an array of fixed or immobilized nucleic acids May. 16, 2017
  • Patent Title: Processes for detecting or quantifying nucleic acids using an array of fixed or immobilized nucleic acids May. 02, 2017
  • Patent Title: Diagnosis and treatment of viral diseases Apr. 11, 2017
  • Patent Title: Processes for detecting or quantifying nucleic acids using an array of fixed or immobilized nucleic acids Apr. 11, 2017
  • Patent Title: Method for treating crohn's disease or ulcerative colitis by administering a compound which binds ldl-receptor-related protein (lrp) ligand binding domain Nov. 15, 2016
  • Patent Title: Autophagy and phospholipidosis pathway assays Feb. 02, 2016
  • Patent Title: Dyes and compositions, and processes for using same in analysis of protein aggregation and other applications Sep. 15, 2015
  • Patent Title: Compounds and assays for controlling wnt activity Jun. 09, 2015
  • Patent Title: Method for treating inflammation by administering a compound which binds ldl-receptor-related protein (lrp) ligand binding domain Jun. 02, 2015
  • Patent Title: Compositions and methods for bone formation and modeling Mar. 03, 2015
  • Patent Title: Non-ionically bound constructs, and compositions and kits comprising domains Sep. 30, 2014
  • Patent Title: Transmucosal administration of aggregated antigens Jun. 24, 2014
  • Patent Title: Property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses Jun. 03, 2014
  • Patent Title: Property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses May. 27, 2014
  • Patent Title: Compositions and methods for bone formation and remodeling Jan. 28, 2014
  • Patent Title: Fluorescent dyes and compounds, methods and kits useful for identifying specific organelles and regions in cells of interest Jan. 29, 2013
  • Patent Title: Compositions and methods for the stimulation or enhancement of bone formation and the self-renewal of cells Jan. 01, 2013
  • Patent Title: Polynucleotides comprising intercalating entities Dec. 18, 2012
  • Patent Title: Selective detection of oncogenic hpv Feb. 28, 2012
  • Patent Title: Nucleic acid sequencing processes using non-radioactive detectable modified or labeled nucleotides or nucleotide analogs, and other processes for nucleic acid detection and chromosomal characterization using such non-radioactive detectable modified or labeled nucleotides or nucleotide analogs Jan. 17, 2012
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to ENZ from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
ENZ News

Recent insights relating to ENZ

CNBC Recommendations

Recent picks made for ENZ stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ENZ

ENZ Analyst Ratings

ENZ Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
ENZ Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $ENZ stock a Buy, Sell, or Hold?

  • What is the price target for $ENZ stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

ENZ Top Shareholders
Shareholder
Shares Held
ENZ Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $ENZ stock?

  • Who owns the most shares of $ENZ stock?

  • What funds own $ENZ stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

ENZ Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view ENZ Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About ENZ

No description available

ENZ (ENZ) Historical Stock Prices

ENZ (ENZ) closed at $0.3138 on April 17, 2025. Over the past year its adjusted close ranged from $0.2608 to $1.25. Daily prices go back to January 2, 2014, 2,841 trading days in all.

  • 1 month-36.80%
  • 3 months-52.81%
  • Year to date-56.07%
  • 1 year-72.71%
  • 3 years-88.99%
  • 5 years-86.87%
  • Max-88.22%
See every congressional and insider trade on the ENZ price chart

Quiver Premium charts ENZ's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Apr 17, 2025 0.3702 0.4000 0.3138 0.3138 0.3138 4,123,861
Apr 16, 2025 0.3259 0.4190 0.3160 0.3816 0.3816 930,605
Apr 15, 2025 0.3310 0.3800 0.3250 0.3360 0.3360 580,825
Apr 14, 2025 0.3200 0.3550 0.3000 0.3490 0.3490 311,574
Apr 11, 2025 0.2860 0.3250 0.2860 0.3240 0.3240 580,157
Apr 10, 2025 0.3300 0.3490 0.2608 0.2608 0.2608 531,818
Apr 9, 2025 0.3000 0.3410 0.2828 0.3341 0.3341 1,102,449
Apr 8, 2025 0.3000 0.3400 0.2700 0.3250 0.3250 312,102
Apr 7, 2025 0.3100 0.3289 0.2612 0.2908 0.2908 525,889
Apr 4, 2025 0.3400 0.3400 0.2520 0.2900 0.2900 559,055
Apr 3, 2025 0.3300 0.3400 0.3000 0.3186 0.3186 346,154
Apr 2, 2025 0.3449 0.3600 0.3100 0.3325 0.3325 435,590
Apr 1, 2025 0.3400 0.3600 0.3100 0.3400 0.3400 704,396
Mar 31, 2025 0.3101 0.3700 0.3101 0.3700 0.3700 918,753
Mar 28, 2025 0.4137 0.4510 0.4137 0.4313 0.4313 140,349
Mar 27, 2025 0.4364 0.4675 0.4169 0.4265 0.4265 124,009
Mar 26, 2025 0.4600 0.4999 0.4400 0.4400 0.4400 42,423
Mar 25, 2025 0.4900 0.4900 0.4530 0.4700 0.4700 60,855
Mar 24, 2025 0.4900 0.5200 0.4700 0.4899 0.4899 81,203
Mar 21, 2025 0.5000 0.5199 0.4734 0.4861 0.4861 91,984
Mar 20, 2025 0.4900 0.5050 0.4849 0.4900 0.4900 108,392
Mar 19, 2025 0.4950 0.5344 0.4878 0.4938 0.4938 67,846
Mar 18, 2025 0.5166 0.5300 0.4900 0.4965 0.4965 348,912
Mar 17, 2025 0.4524 0.4916 0.4506 0.4701 0.4701 18,868
Mar 14, 2025 0.5000 0.5000 0.4710 0.4974 0.4974 38,239
Mar 13, 2025 0.5000 0.5000 0.4572 0.4610 0.4610 86,262
Mar 12, 2025 0.4522 0.4992 0.4401 0.4600 0.4600 125,045
Mar 11, 2025 0.4601 0.4848 0.4401 0.4490 0.4490 136,909
Mar 10, 2025 0.4800 0.5050 0.4601 0.4601 0.4601 144,768
Mar 7, 2025 0.4800 0.5085 0.4606 0.4640 0.4640 107,565
Mar 6, 2025 0.4870 0.5035 0.4701 0.4790 0.4790 67,202
Mar 5, 2025 0.4700 0.4989 0.4686 0.4720 0.4720 45,805
Mar 4, 2025 0.4900 0.4992 0.4601 0.4650 0.4650 63,015
Mar 3, 2025 0.5000 0.5110 0.4758 0.4851 0.4851 86,748
Feb 28, 2025 0.4921 0.5122 0.4700 0.4810 0.4810 65,101
Feb 27, 2025 0.4900 0.5200 0.4850 0.4921 0.4921 116,853
Feb 26, 2025 0.4950 0.5300 0.4861 0.4862 0.4862 38,597
Feb 25, 2025 0.5001 0.5001 0.4861 0.5000 0.5000 215,318
Feb 24, 2025 0.5050 0.5100 0.4929 0.5024 0.5024 159,211
Feb 21, 2025 0.5200 0.5286 0.5050 0.5164 0.5164 73,058
Feb 20, 2025 0.5100 0.5380 0.5100 0.5273 0.5273 79,369
Feb 19, 2025 0.5400 0.5471 0.5000 0.5181 0.5181 111,487
Feb 18, 2025 0.5600 0.5600 0.4600 0.5016 0.5016 358,385
Feb 14, 2025 0.5000 0.5695 0.4950 0.5451 0.5451 163,741
Feb 13, 2025 0.4800 0.5100 0.4500 0.5100 0.5100 388,407
Feb 12, 2025 0.5290 0.5428 0.4122 0.4758 0.4758 598,334
Feb 11, 2025 0.5600 0.5635 0.5100 0.5230 0.5230 315,150
Feb 10, 2025 0.5432 0.5700 0.5354 0.5400 0.5400 81,940
Feb 7, 2025 0.5700 0.5750 0.5395 0.5600 0.5600 124,601
Feb 6, 2025 0.5708 0.6000 0.5651 0.5750 0.5750 134,561
Feb 5, 2025 0.5900 0.5995 0.5610 0.5885 0.5885 89,068
Feb 4, 2025 0.6100 0.6147 0.5677 0.5860 0.5860 241,279
Feb 3, 2025 0.6010 0.6091 0.5800 0.5826 0.5826 135,990
Jan 31, 2025 0.6200 0.6200 0.5935 0.6059 0.6059 58,502
Jan 30, 2025 0.6301 0.6302 0.5910 0.5998 0.5998 133,664
Jan 29, 2025 0.6300 0.6452 0.6230 0.6305 0.6305 114,924
Jan 28, 2025 0.6479 0.6550 0.6200 0.6374 0.6374 104,491
Jan 27, 2025 0.6443 0.6580 0.6300 0.6570 0.6570 148,437
Jan 24, 2025 0.6689 0.6690 0.6433 0.6531 0.6531 163,320
Jan 23, 2025 0.6500 0.6700 0.6500 0.6580 0.6580 80,407
Jan 22, 2025 0.6868 0.6868 0.6570 0.6570 0.6570 69,428
Jan 21, 2025 0.6603 0.6777 0.6550 0.6755 0.6755 81,999
Jan 17, 2025 0.6800 0.6944 0.6450 0.6550 0.6550 121,710
Jan 16, 2025 0.7200 0.7200 0.6506 0.6650 0.6650 96,548
Jan 15, 2025 0.6500 0.7128 0.6306 0.6998 0.6998 307,223
Jan 14, 2025 0.6600 0.6800 0.6500 0.6500 0.6500 108,014
Jan 13, 2025 0.6800 0.6995 0.6477 0.6643 0.6643 109,374
Jan 10, 2025 0.6810 0.7100 0.6800 0.6800 0.6800 95,430
Jan 8, 2025 0.6900 0.7201 0.6811 0.7063 0.7063 80,971
Jan 7, 2025 0.7100 0.7409 0.7000 0.7053 0.7053 105,308
Jan 6, 2025 0.7300 0.7554 0.7201 0.7244 0.7244 57,280
Jan 3, 2025 0.7339 0.7447 0.7200 0.7360 0.7360 89,944
Jan 2, 2025 0.7110 0.7500 0.7110 0.7201 0.7201 134,322
Dec 31, 2024 0.7021 0.7385 0.6950 0.7143 0.7143 171,315
Dec 30, 2024 0.7150 0.7358 0.6913 0.7030 0.7030 214,296
Dec 27, 2024 0.7000 0.7280 0.6901 0.7280 0.7280 171,478
Dec 26, 2024 0.7369 0.7398 0.7077 0.7083 0.7083 91,407
Dec 24, 2024 0.7450 0.7450 0.7100 0.7269 0.7269 34,679
Dec 23, 2024 0.7600 0.7800 0.7400 0.7410 0.7410 96,498
Dec 20, 2024 0.7100 0.7800 0.7100 0.7627 0.7627 450,647
Dec 19, 2024 0.7000 0.7600 0.6950 0.7125 0.7125 220,721
Dec 18, 2024 0.7070 0.7268 0.6906 0.7051 0.7051 323,920
Dec 17, 2024 0.9300 0.9300 0.6823 0.7000 0.7000 1,735,162
Dec 16, 2024 1.03 1.03 1.01 1.01 1.01 85,553
Dec 13, 2024 1.01 1.05 1.00 1.02 1.02 155,411
Dec 12, 2024 1.03 1.04 1.01 1.03 1.03 100,617
Dec 11, 2024 1.03 1.06 1.03 1.03 1.03 60,509
Dec 10, 2024 1.07 1.08 1.04 1.06 1.06 75,739
Dec 9, 2024 1.05 1.07 1.04 1.05 1.05 88,293
Dec 6, 2024 1.02 1.09 1.02 1.05 1.05 54,832
Dec 5, 2024 1.05 1.05 1.02 1.04 1.04 55,624
Dec 4, 2024 1.09 1.09 1.04 1.06 1.06 48,485
Dec 3, 2024 1.06 1.13 1.03 1.07 1.07 231,983
Dec 2, 2024 1.09 1.10 1.06 1.07 1.07 190,502
Nov 29, 2024 1.01 1.10 1.01 1.08 1.08 203,024
Nov 27, 2024 1.06 1.07 1.02 1.03 1.03 101,470
Nov 26, 2024 1.00 1.05 1.00 1.04 1.04 198,447
Nov 25, 2024 0.9500 1.00 0.9451 0.9750 0.9750 212,334
Nov 22, 2024 0.9700 0.9900 0.9302 0.9700 0.9700 106,791
Nov 21, 2024 0.9800 1.02 0.9602 0.9700 0.9700 163,691
Nov 20, 2024 1.01 1.02 0.9700 0.9871 0.9871 103,826
Nov 19, 2024 1.02 1.04 1.01 1.01 1.01 109,256
Nov 18, 2024 1.04 1.06 1.02 1.02 1.02 96,791
Nov 15, 2024 1.10 1.10 1.02 1.04 1.04 194,009
Nov 14, 2024 1.15 1.16 1.12 1.14 1.14 205,441
Nov 13, 2024 1.15 1.16 1.13 1.14 1.14 131,363
Nov 12, 2024 1.15 1.16 1.14 1.16 1.16 87,449
Nov 11, 2024 1.15 1.18 1.13 1.14 1.14 198,215
Nov 8, 2024 1.13 1.15 1.12 1.15 1.15 115,130
Nov 7, 2024 1.12 1.15 1.12 1.13 1.13 170,895
Nov 6, 2024 1.15 1.15 1.12 1.13 1.13 173,473
Nov 5, 2024 1.15 1.15 1.11 1.12 1.12 144,112
Nov 4, 2024 1.13 1.15 1.09 1.13 1.13 280,251
Nov 1, 2024 1.14 1.16 1.13 1.13 1.13 45,873
Oct 31, 2024 1.14 1.18 1.12 1.15 1.15 66,871
Oct 30, 2024 1.16 1.19 1.14 1.15 1.15 331,082
Oct 29, 2024 1.14 1.14 1.12 1.13 1.13 24,761
Oct 28, 2024 1.13 1.15 1.12 1.12 1.12 38,312
Oct 25, 2024 1.17 1.17 1.14 1.14 1.14 20,938
Oct 24, 2024 1.13 1.16 1.12 1.16 1.16 35,557
Oct 23, 2024 1.18 1.18 1.13 1.14 1.14 43,448
Oct 22, 2024 1.14 1.18 1.14 1.16 1.16 100,199
Oct 21, 2024 1.14 1.16 1.13 1.14 1.14 40,918
Oct 18, 2024 1.15 1.15 1.12 1.15 1.15 78,449
Oct 17, 2024 1.11 1.15 1.11 1.13 1.13 25,716
Oct 16, 2024 1.13 1.15 1.12 1.13 1.13 36,343
Oct 15, 2024 1.13 1.15 1.13 1.13 1.13 51,148
Oct 14, 2024 1.13 1.15 1.13 1.13 1.13 42,287
Oct 11, 2024 1.12 1.15 1.12 1.14 1.14 49,762
Oct 10, 2024 1.12 1.17 1.12 1.12 1.12 111,963
Oct 9, 2024 1.13 1.14 1.12 1.14 1.14 32,949
Oct 8, 2024 1.13 1.14 1.12 1.13 1.13 14,684
Oct 7, 2024 1.13 1.14 1.11 1.13 1.13 32,465
Oct 4, 2024 1.11 1.16 1.11 1.14 1.14 92,098
Oct 3, 2024 1.12 1.15 1.12 1.13 1.13 17,718
Oct 2, 2024 1.10 1.15 1.10 1.14 1.14 56,265
Oct 1, 2024 1.12 1.13 1.09 1.11 1.11 92,183
Sep 30, 2024 1.13 1.15 1.10 1.12 1.12 81,334
Sep 27, 2024 1.13 1.13 1.09 1.13 1.13 60,153
Sep 26, 2024 1.11 1.15 1.10 1.14 1.14 298,121
Sep 25, 2024 1.12 1.13 1.10 1.12 1.12 34,454
Sep 24, 2024 1.15 1.15 1.11 1.12 1.12 187,419
Sep 23, 2024 1.19 1.19 1.12 1.16 1.16 47,703
Sep 20, 2024 1.13 1.18 1.11 1.18 1.18 54,161
Sep 19, 2024 1.12 1.14 1.12 1.14 1.14 49,919
Sep 18, 2024 1.11 1.14 1.11 1.11 1.11 45,142
Sep 17, 2024 1.12 1.13 1.11 1.12 1.12 41,711
Sep 16, 2024 1.10 1.13 1.10 1.11 1.11 26,863
Sep 13, 2024 1.12 1.13 1.10 1.11 1.11 53,798
Sep 12, 2024 1.09 1.13 1.09 1.13 1.13 13,098
Sep 11, 2024 1.10 1.14 1.09 1.11 1.11 62,898
Sep 10, 2024 1.12 1.14 1.10 1.13 1.13 79,635
Sep 9, 2024 1.12 1.14 1.09 1.14 1.14 15,096
Sep 6, 2024 1.13 1.13 1.09 1.12 1.12 9,906
Sep 5, 2024 1.11 1.13 1.07 1.11 1.11 25,191
Sep 4, 2024 1.11 1.13 1.10 1.12 1.12 23,287
Sep 3, 2024 1.14 1.14 1.07 1.13 1.13 85,144
Aug 30, 2024 1.15 1.15 1.13 1.14 1.14 11,648
Aug 29, 2024 1.13 1.17 1.12 1.15 1.15 52,616
Aug 28, 2024 1.12 1.16 1.12 1.16 1.16 71,326
Aug 27, 2024 1.13 1.14 1.12 1.14 1.14 34,139
Aug 26, 2024 1.12 1.14 1.12 1.13 1.13 13,317
Aug 23, 2024 1.12 1.16 1.12 1.14 1.14 56,933
Aug 22, 2024 1.11 1.14 1.11 1.14 1.14 41,642
Aug 21, 2024 1.09 1.14 1.09 1.11 1.11 38,789
Aug 20, 2024 1.11 1.14 1.10 1.11 1.11 76,217
Aug 19, 2024 1.13 1.14 1.11 1.12 1.12 41,426
Aug 16, 2024 1.11 1.13 1.10 1.13 1.13 86,314
Aug 15, 2024 1.09 1.14 1.09 1.11 1.11 82,623
Aug 14, 2024 1.08 1.10 1.07 1.10 1.10 84,115
Aug 13, 2024 1.06 1.11 1.03 1.08 1.08 315,633
Aug 12, 2024 1.10 1.11 1.04 1.05 1.05 54,409
Aug 9, 2024 1.06 1.08 1.05 1.06 1.06 118,142
Aug 8, 2024 1.11 1.11 1.07 1.08 1.08 32,199
Aug 7, 2024 1.07 1.08 1.05 1.07 1.07 53,782
Aug 6, 2024 1.06 1.08 1.06 1.06 1.06 49,670
Aug 5, 2024 1.03 1.09 1.02 1.06 1.06 132,218
Aug 2, 2024 1.11 1.11 1.08 1.10 1.10 127,523
Aug 1, 2024 1.13 1.14 1.11 1.12 1.12 54,291
Jul 31, 2024 1.14 1.14 1.12 1.14 1.14 47,858
Jul 30, 2024 1.12 1.15 1.12 1.13 1.13 68,940
Jul 29, 2024 1.15 1.15 1.11 1.12 1.12 45,157
Jul 26, 2024 1.12 1.16 1.12 1.15 1.15 53,740
Jul 25, 2024 1.17 1.17 1.12 1.14 1.14 73,697
Jul 24, 2024 1.15 1.17 1.13 1.17 1.17 28,698
Jul 23, 2024 1.15 1.16 1.13 1.14 1.14 65,287
Jul 22, 2024 1.13 1.17 1.12 1.17 1.17 59,392
Jul 19, 2024 1.15 1.16 1.13 1.14 1.14 104,022
Jul 18, 2024 1.16 1.18 1.13 1.13 1.13 102,107
Jul 17, 2024 1.18 1.19 1.15 1.17 1.17 254,730
Jul 16, 2024 1.14 1.19 1.10 1.18 1.18 164,311
Jul 15, 2024 1.16 1.20 1.15 1.17 1.17 92,158
Jul 12, 2024 1.10 1.16 1.10 1.16 1.16 87,843
Jul 11, 2024 1.09 1.12 1.08 1.11 1.11 94,353
Jul 10, 2024 1.06 1.09 1.00 1.08 1.08 247,280
Jul 9, 2024 1.03 1.06 1.03 1.06 1.06 93,516
Jul 8, 2024 1.03 1.06 1.01 1.04 1.04 62,871
Jul 5, 2024 1.04 1.06 1.00 1.06 1.06 148,832
Jul 3, 2024 1.08 1.08 0.9950 1.07 1.07 106,851
Jul 2, 2024 1.11 1.13 1.07 1.07 1.07 24,984
Jul 1, 2024 1.07 1.13 1.06 1.11 1.11 110,411
Jun 28, 2024 1.07 1.09 1.01 1.09 1.09 249,564
Jun 27, 2024 1.09 1.09 1.02 1.09 1.09 427,921
Jun 26, 2024 1.08 1.10 1.03 1.08 1.08 180,411
Jun 25, 2024 1.08 1.10 1.06 1.09 1.09 252,401
Jun 24, 2024 1.15 1.15 1.06 1.10 1.10 169,602
Jun 21, 2024 1.09 1.12 1.05 1.12 1.12 209,770
Jun 20, 2024 1.12 1.15 1.06 1.09 1.09 181,485
Jun 18, 2024 1.09 1.13 1.07 1.08 1.08 82,330
Jun 17, 2024 1.16 1.16 1.09 1.11 1.11 88,498
Jun 14, 2024 1.24 1.24 1.08 1.16 1.16 194,437
Jun 13, 2024 1.13 1.15 1.10 1.13 1.13 76,722
Jun 12, 2024 1.17 1.18 1.15 1.16 1.16 53,070
Jun 11, 2024 1.16 1.19 1.13 1.19 1.19 43,040
Jun 10, 2024 1.12 1.18 1.10 1.16 1.16 84,190
Jun 7, 2024 1.17 1.18 1.12 1.13 1.13 76,096
Jun 6, 2024 1.15 1.20 1.15 1.17 1.17 19,594
Jun 5, 2024 1.18 1.18 1.10 1.16 1.16 39,407
Jun 4, 2024 1.21 1.23 1.11 1.15 1.15 113,277
Jun 3, 2024 1.21 1.24 1.14 1.20 1.20 138,694
May 31, 2024 1.19 1.23 1.13 1.19 1.19 82,342
May 30, 2024 1.25 1.25 1.13 1.16 1.16 339,772
May 29, 2024 1.18 1.27 1.17 1.25 1.25 282,236
May 28, 2024 1.11 1.20 1.08 1.18 1.18 389,617
May 24, 2024 1.03 1.08 1.03 1.07 1.07 50,524
May 23, 2024 1.05 1.09 1.04 1.05 1.05 116,502
May 22, 2024 1.07 1.07 1.03 1.06 1.06 228,400
May 21, 2024 1.09 1.11 1.05 1.05 1.05 60,745
May 20, 2024 1.12 1.13 1.08 1.11 1.11 42,397
May 17, 2024 1.11 1.13 1.07 1.09 1.09 31,340
May 16, 2024 1.11 1.14 1.09 1.11 1.11 105,655
May 15, 2024 1.11 1.11 1.06 1.10 1.10 48,395
May 14, 2024 1.12 1.12 1.06 1.09 1.09 81,861
May 13, 2024 1.06 1.12 1.06 1.09 1.09 255,787
May 10, 2024 1.06 1.06 1.03 1.04 1.04 79,316
May 9, 2024 1.13 1.13 1.04 1.04 1.04 133,872
May 8, 2024 1.07 1.12 1.07 1.12 1.12 92,722
May 7, 2024 1.07 1.12 1.07 1.09 1.09 82,967
May 6, 2024 1.02 1.09 0.9901 1.07 1.07 291,555
May 3, 2024 1.04 1.08 1.02 1.04 1.04 73,102
May 2, 2024 1.05 1.06 1.03 1.04 1.04 46,577
May 1, 2024 1.03 1.05 1.03 1.04 1.04 50,051
Apr 30, 2024 1.04 1.06 1.01 1.04 1.04 89,673
Apr 29, 2024 1.07 1.08 1.05 1.06 1.06 32,458
Apr 26, 2024 1.07 1.07 1.04 1.05 1.05 114,913
Apr 25, 2024 1.04 1.09 1.04 1.07 1.07 74,257
Apr 24, 2024 1.10 1.10 1.05 1.06 1.06 77,230
Apr 23, 2024 1.08 1.11 1.08 1.09 1.09 76,123
Apr 22, 2024 1.08 1.11 1.07 1.09 1.09 120,187
Apr 19, 2024 1.11 1.11 1.07 1.09 1.09 258,158
Apr 18, 2024 1.14 1.14 1.07 1.13 1.13 203,077
Apr 17, 2024 1.13 1.16 1.13 1.15 1.15 123,985

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
ENZ Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at ENZ, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation